ES2149158T3 - Inhibidores y sustratos de la trombina. - Google Patents

Inhibidores y sustratos de la trombina.

Info

Publication number
ES2149158T3
ES2149158T3 ES91919539T ES91919539T ES2149158T3 ES 2149158 T3 ES2149158 T3 ES 2149158T3 ES 91919539 T ES91919539 T ES 91919539T ES 91919539 T ES91919539 T ES 91919539T ES 2149158 T3 ES2149158 T3 ES 2149158T3
Authority
ES
Spain
Prior art keywords
sub
substrates
pro
thrombin inhibitors
certain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919539T
Other languages
English (en)
Inventor
Vijay Vir Kakkar
John Joseph Deadman
Goran Karl Claeson
Leifeng Cheng
Naoyashi Chino
Said Mohamed Anwar Elgendy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trigen Ltd
Original Assignee
Trigen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trigen Ltd filed Critical Trigen Ltd
Application granted granted Critical
Publication of ES2149158T3 publication Critical patent/ES2149158T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PEPTIDOS QUE ACTUAN COMO INHIBIDORES O SUBSTRATOS DE LA TROMBINA SE DERIVAN DE LA FORMULA D LOGOS, EN DONDE PHE SE ENCUENTRA SUBSTITUIDO POR (A), EN DONDE AR1 Y AR2 SON IGUALES O DIFERENTES Y SE ENCUENTRAN SELECCIONADAS ENTRE EL GRUPO QUE CONSTA DE FENIL, TIENIL, PIRIDIL, NAFTIL, TIONAFTIL, INDOLIL Y GRUPOS SATURADOS QUE SE CORRESPONDAN CON ESTOS, OPCIONALMENTE SUSBSTITUIDOS POR HASTA 3 GRUPOS SELECCIONADOS ENTRE ALQUIL C1 ALES O DIFERENTES Y SE ENCUENTRAN SELECCIONADAS ENTRE EL GRUPO QUE CONSTAN DE CH2, CH2 O GRUPOS SATURADOS QUE SE CORRESPONDAN CON ESTOS, PERO UNO DE AR BENCIL, Y ARG PUEDE ESTAR SUBSTITUIDO POR UN ACIDO AMINO DE LA FORMULA (B), EN DONDE Y = [CH2]N -Q, (C), DONDE Q = H, AMINO, AMIDINO, IMIDAZOLA, GUANIDINO O ISOTIOUREIDO Y N = 1 ERIBLEMENTE 3 IL OPCIONALMENTE SUBSTITUIDO POR HASTA TRES GRUPOS SELECCIONADOS ENTRE HIDROXIDO Y ALCOXIDO C1 EN DONDE R1 = H, OH, CH2CL, CH2 CO PRO QUE CONSTA DE OH, OR6 Y NR6R7, O R2 Y R3 TOMADAS JUNTAS REPRESENTAN EL RESIDUO DE UN DIOL; EN DONDER6 Y R7, QUE PUEDEN SER IGUALES O DIFERENTES, SON ALQUIL C1 -C10, FENIL O ARILALQUIL C6 ENTRE R2, R3, GLI
ES91919539T 1990-11-06 1991-11-06 Inhibidores y sustratos de la trombina. Expired - Lifetime ES2149158T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909024129A GB9024129D0 (en) 1990-11-06 1990-11-06 Inhibitors and substrates of thrombin

Publications (1)

Publication Number Publication Date
ES2149158T3 true ES2149158T3 (es) 2000-11-01

Family

ID=10684957

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91919539T Expired - Lifetime ES2149158T3 (es) 1990-11-06 1991-11-06 Inhibidores y sustratos de la trombina.

Country Status (14)

Country Link
US (1) US5858979A (es)
EP (3) EP0807638A1 (es)
JP (2) JP3173786B2 (es)
AT (1) ATE195531T1 (es)
AU (1) AU636521B2 (es)
DE (2) DE69132369D1 (es)
DK (1) DK0509080T3 (es)
ES (1) ES2149158T3 (es)
GB (1) GB9024129D0 (es)
GR (1) GR3034839T3 (es)
IE (2) IE913871A1 (es)
NZ (2) NZ264128A (es)
WO (1) WO1992007869A1 (es)
ZA (1) ZA918805B (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009134A1 (en) * 1991-11-06 1993-05-13 The Scripps Research Institute Phosphonamidate ester-containing pseudopeptides
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US6387881B1 (en) * 1992-09-19 2002-05-14 Trigen Ltd Inhibitors and substrates of thrombin
WO1994017817A1 (en) * 1993-02-12 1994-08-18 Corvas International, Inc. Inhibitors of thrombosis
FR2701951B1 (fr) * 1993-02-24 1995-06-09 Adir Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO1994021650A1 (en) * 1993-03-24 1994-09-29 The Du Pont Merck Pharmaceutical Company Boronic acid and ester inhibitors of thrombin
IL109319A0 (en) * 1993-04-27 1994-07-31 Du Pont Merck Pharma Amidino and guanidino substituted boronic acid compounds
CA2159834A1 (en) * 1993-04-30 1994-11-10 Daniel F. Veber Thrombin inhibitors
US5780631A (en) * 1993-06-03 1998-07-14 Astra Aktiebolag Starting materials in the synthesis of thrombin and kininogenase inhibitors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
GB9318637D0 (en) * 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
IL111175A0 (en) * 1993-10-07 1994-12-29 Du Pont Merck Pharma Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
IL111176A0 (en) * 1993-10-07 1994-12-29 Du Pont Merck Pharma Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them
WO1995009859A1 (en) * 1993-10-07 1995-04-13 The Du Pont Merck Pharmaceutical Company Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
US5462964A (en) * 1993-10-20 1995-10-31 The Du Pont Merck Pharmaceutical Company Dipeptide boronic acid inhibitors of trypsin-like enzymes
US6060462A (en) * 1993-10-20 2000-05-09 Dupont Pharmaceuticals Company Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
US5686419A (en) * 1994-01-21 1997-11-11 Georgia Tech Research Corp. Basic α-aminoalkylphosphonate derivatives
US5693617A (en) * 1994-03-15 1997-12-02 Proscript, Inc. Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
FR2721611B1 (fr) * 1994-06-22 1996-09-27 Adir Nouveaux dérivés peptidiques de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent .
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
GB9502985D0 (en) * 1995-02-16 1995-04-05 Thrombosis Res Inst Enzyme inhibitors
US6030972A (en) * 1995-02-17 2000-02-29 Basf Aktiengesellschaft Dipeptide amidines as thrombin inhibitors
US5629324A (en) * 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
TWI238827B (en) 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
EP1890483A3 (en) 1996-07-23 2011-07-06 Canon Kabushiki Kaisha Camera control apparatus and method
US6004955A (en) * 1996-08-15 1999-12-21 Dupont Pharmaceuticals Company Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
JP2002501081A (ja) 1998-01-26 2002-01-15 ビーエーエスエフ アクチェンゲゼルシャフト トロンビンインヒビター
JP2003504301A (ja) 1998-04-01 2003-02-04 ブリストル−マイヤーズ スクイブ ファーマ カンパニー インテグリンアンタゴニスト
CA2348740A1 (en) 1998-12-23 2000-07-06 Ruth R. Wexler Thrombin or factor xa inhibitors
AU3192500A (en) * 1999-03-16 2000-10-04 C & C Research Laboratories Substituted proline derivatives and medicinal compositions containing the same
IL147970A0 (en) * 1999-08-09 2002-09-12 Tripep Ab Pharmaceutical compositions containing tripeptides
US6258932B1 (en) * 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
AU2002230836A1 (en) 2000-12-18 2002-07-01 Merck & Co., Inc. Benzylamine derivatives and their use as thrombin inhibitors
US6528503B2 (en) 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
CA2436176A1 (en) 2001-02-09 2002-08-22 Merck & Co., Inc. Thrombin inhibitors
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) * 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
WO2003024995A1 (en) * 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
US7084134B2 (en) 2002-05-02 2006-08-01 Merk & Co., Inc. Thrombin inhibitors
US20050288253A1 (en) 2002-09-09 2005-12-29 Trigen Limited Boronic acid salts
BR0314450A (pt) * 2002-09-09 2005-07-26 Trigen Ltd Sais de ácido borÈnico com adição de uma base farmaceuticamente aceitável, formulação farmacêutica, e uso dos referidos sais para preparar uma formulação farmacêutica
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
KR20050101221A (ko) * 2003-02-21 2005-10-20 트리펩 아베 Ｈｉｖ 복제의 억제를 위한 글리신아미드 유도체
GB0405267D0 (en) * 2004-03-09 2004-04-21 Trigen Ltd Compounds
EP1724253A3 (en) * 2005-05-10 2009-11-04 Ajinomoto Co., Inc. Production method of optically active diphenylalanine compounds
WO2008104271A2 (en) * 2007-02-28 2008-09-04 Sanofi-Aventis Imaging probes
WO2013185113A1 (en) 2012-06-08 2013-12-12 Biogen Idec Ma Inc. Procoagulant compounds
CA2875247A1 (en) 2012-06-08 2013-12-12 Biogen Idec Ma Inc. Chimeric clotting factors
PL3472149T3 (pl) 2016-06-21 2024-02-12 Orion Ophthalmology LLC Heterocykliczne pochodne prolinamidu
US10526315B2 (en) 2016-06-21 2020-01-07 Orion Ophthalmology LLC Carbocyclic prolinamide derivatives
DE102016009766A1 (de) 2016-08-11 2018-02-15 Julius-Maximilians-Universität Würzburg Herstellung von Bitterstoffderivaten
AU2022306289A1 (en) 2021-07-09 2024-01-18 Aligos Therapeutics, Inc. Anti-viral compounds
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428874A (en) * 1981-03-25 1984-01-31 Pentapharm A.G. Tripeptide derivatives
JPS5856695A (ja) * 1981-09-28 1983-04-04 Nitto Boseki Co Ltd 新規なトロンビン測定用基質
US4499082A (en) * 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
DE3606480A1 (de) * 1986-02-28 1987-09-03 Behringwerke Ag Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US4929602A (en) * 1987-11-25 1990-05-29 Scripps Clinic And Research Foundation Method of inhibiting platelet dependent arterial thrombosis
US5023236A (en) * 1988-04-07 1991-06-11 Corvas, Inc. Factor VII/VIIA active site inhibitors
US5288707A (en) * 1990-08-13 1994-02-22 Sandoz Ltd. Borolysine peptidomimetics

Also Published As

Publication number Publication date
WO1992007869A1 (en) 1992-05-14
NZ240477A (en) 1994-10-26
AU636521B2 (en) 1993-04-29
AU8900791A (en) 1992-05-26
EP0807638A1 (en) 1997-11-19
GB9024129D0 (en) 1990-12-19
IE913871A1 (en) 1992-05-22
US5858979A (en) 1999-01-12
JP3173786B2 (ja) 2001-06-04
DE69132369D1 (en) 2000-09-21
ATE195531T1 (de) 2000-09-15
DE69132369T2 (de) 2001-02-22
JP2001226397A (ja) 2001-08-21
ZA918805B (en) 1993-04-28
EP0955309A1 (en) 1999-11-10
JP3453357B2 (ja) 2003-10-06
IE20000539A1 (en) 2002-03-20
JPH05504775A (ja) 1993-07-22
DK0509080T3 (da) 2000-09-18
EP0509080B1 (en) 2000-08-16
DE69132369T4 (de) 2001-09-13
GR3034839T3 (en) 2001-02-28
NZ264128A (en) 1996-11-26
EP0509080A1 (en) 1992-10-21

Similar Documents

Publication Publication Date Title
ES2149158T3 (es) Inhibidores y sustratos de la trombina.
AU645347B2 (en) Tripeptide antithrombotic agents
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
CA2136622A1 (fr) Composes biologiquement actifs de type phosphotriesters
EP0181110A3 (en) Histidine derivatives as renin inhibitors
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
ATE130312T1 (de) Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen.
IT1241674B (it) Acidi gem-difosfonici, un processo per la loro preparazione e composizioni farmaceutiche che li contengono.
KR840005733A (ko) 무라밀 펩타이드의 제조방법
Shiozaki et al. SYNTHESIS OF 3-HYDROXYETHYL-4-OXOAZETIDIN-2-YLPHOSPHONATE DERIVATIVES
PH24150A (en) Orally active phosphonyl hydroxyacyl prolines
ES467259A1 (es) Procedimiento para la obtencion de arilhexafuranosidos.
ES480969A1 (es) Procedimiento para la aclaracion optica de materiales organicos, en especial de tipo textil.
EP0314239A3 (en) Tripeptide renin inhibitors with n-terminal ureido or sulfamido groups
MY111431A (en) Tripeptide antithrombotic agents
KR870001226A (ko) 바이사이클 화합물의 제조방법
ES445895A1 (es) Procedimiento para la produccion de nuevos peptidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509080

Country of ref document: ES